company
핵심인력

SCROLL DOWN
MEMBERS 핵심인력
CEO
  • PhD 권용태
    • CEO, AUTOTAC Bio Inc.
    • PhD in Molecular Biology, Seoul National University
    • MS in Molecular Biology, Seoul National University
    • Director, Cellular Degradation Biology Center, Seoul National University
    • Professor (tenure), Seoul National University
    • Associate Professor (tenure), University of Pittsburgh
    • Senior Scientist, Key Staff, California Institute of Technology
R&D
  • PhD 김현태
    • Executive Director, Institute for Chemistry R&D Center
    • PhD in Structural Biology, College of Life Sciences and Biotechnology, Korea University
    • Protein structure determination and modelling study
    • Member of CDISC_K3C (Korean CDISC Coordinating Committee)
    • Former Biology Senior Leader, CrystalGenomics R&D
    • (License out) 1) 454 M USD : oral anemia medication / hypoxia to ProQuest investment 2) 331 M USD: CG806 (AML) to Aptose
    • (New drug development) Acelex, the 22nd developed medicine in Korea. Identifed MOA of Acelex.
  • PhD 최설민
    • Executive Director, Medicine Development Center
    • PhD in Toxicology, School of Pharmacy, Sungkyunkwan University
    • BS, Biological Sciences, Sungkyunkwan University
    • Project leader for sarcopenia, dyslipidemia, gastritis/Project team member of Zydena and Stillen at Dong-A ST
    • External Panel of National Research Council of Science & Technology (NIS)
    • Member of KSOT/KEMS, KSAP, KSNS
  • PhD 지창훈
    • Director, Bio R&D Center
    • PhD in Biomedical Science, School of Medicine, Seoul National University
    • BS, Biomedical Engineering, Johns Hopkins University
    • BS, Applied Mathematics and Statistics, Johns Hopkins University
    • In vitro biological evaluation & platform biology development
    • Cellular & molecular biology
  • PhD candidate 성기운
    • Director, Institute for Clinical and Translational Research Center
    • PhD candidate, School of Medicine, Seoul National University
    • BS, Physical Education, Sejong University
    • In vivo efficacy & toxicity evaluation
    • Adjunct Faculty in Kwangwoon University
    • Academician, Korean Society exercise nutrition
  • MS/Veterinarian 정한국
    • Medicine Development Center
    • MS in Veterinary Pathology, College of Veterinary Medicine, Seoul National University
    • BS, College of Veterinary Medicine, Seoul National University
    • Nonclinical toxicology
  • MS 박창민
    • Institute for Chemistry R&D Center
    • MS in Organic Chemistry, Department of Chemistry, Yonsei University
    • Former Deputy General Manager, Department of Organic Synthesis, Kukjepharma
    • Medicinal chemistry, CMC and process development
  • MS 나정은
    • Institute for Chemistry R&D center
    • MS in Organic Chemistry, Department of Chemistry, Chonnam National University
    • Medicinal chemistry research (design and synthesis, CRO management)
  • PhD/KO Pharmacist 이재민
    • Medicine Development Center
    • PhD in Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
    • BS, Oriental Pharmaceutical Science, Kyunghee University
    • Nonclinical development
Management Support
  • CPA/CTA 구자영
    • CFO & Executive Director, Financial Management Division
    • BA, Business Administration, Korea University
    • Audit, tax, financial advice (due diligence, valuation) in PwC Korea
    • Fundraising, planning, risk management in Shinhan Venture Investment
    • Accounting, tax, treasury in Doosan Capital
    • Start-up financial advisory service as Virtual CFO
  • MBA/MS 박영경
    • CBO & Executive Director, Business Development
    • KHIDI emerging market global business development advisor
    • Alliance management and license in and out co-development partnership with various multi-national companies. (E.G. Sanofi, GSK, Lilly and etc.)
  • BSN 이송이
    • Business Development
    • RN in Australia, New Zealand and Korea
    • Licensing, business strategy and alliance management, clinical trial operation
    • 15 years of experience in hospital, healthcare and biotech industry
  •     이효정
    • Financial Management Division
    • Accounting, tax and asset management
    • Human resources management
조직도 오토텍바이오는 체계적인 구조를 바탕으로 바이오 산업과 미래를 향해 나아갑니다.